Boldenone undecylenate
Boldenone undecylenate, or boldenone undecenoate, sold under the brand names Equipoise and Parenabol among others, is an androgen and anabolic steroid (AAS) medication which is used in veterinary medicine, mainly in horses. It was formerly used in humans as well. It is given by injection into muscle.
Clinical data | |
---|---|
Trade names | Boldane, Equipoise, Parenabol, others |
Other names | Boldenone undecenoate; Ba 29038; Boldenone 17β-undec-10-enoate; Δ1-Testosterone 17β-undec-10-enoate; 1-Dehydrotestosterone 17β-undec-10-enoate; Androsta-1,4-dien-17β-ol-3-one 17β-undec-10-enoate |
Pregnancy category |
|
Routes of administration | Intramuscular injection |
Drug class | Androgen; Anabolic steroid; Androgen ester |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | Intramuscular: 14 days |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.032.734 |
Chemical and physical data | |
Formula | C30H44O3 |
Molar mass | 452.679 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
|
Side effects of boldenone undecylenate include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). It has strong anabolic effects and moderate androgenic effects, weak estrogenic effects, and no risk of liver damage. Boldenone undecylenate is an androgen ester and a long-lasting prodrug of boldenone in the body.
Boldenone undecylenate was introduced for medical use in the 1960s. In addition to its medical use, boldenone undecylenate is used to improve physique and performance. The drug is a controlled substance in the United States and its use is generally illicit. It remains marketed for veterinary use in Australia and the United States.